In Vitro Pharmacological Properties of KRH-594, a Novel Angiotensin II Type 1 Receptor Antagonist.

Biological and Pharmaceutical Bulletin - Japan
doi 10.1248/bpb.20.850
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pharmaceutical Society of Japan

Related search

Localization of a Novel Non-Peptide Angiotensin II Type 1 Receptor Antagonist, E4177, in Rat Adrenal Glomerulosa.

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
1996English

Reduction of Bleomycin Induced Lung Fibrosis by Candesartan Cilexetil, an Angiotensin II Type 1 Receptor Antagonist

Thorax
PulmonaryRespiratory Medicine
2004English

Regulation of Angiotensin II Type 1 Receptor mRNA and Protein in Angiotensin II Induced Hypertension

Hypertension
Internal Medicine
1999English

Anti-Inflammatory Properties of a Novel Peptide Interleukin 1 Receptor Antagonist

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2014English

The Angiotensin II Type 1 Receptor and Receptor-Associated Proteins

Cell Research
Cell BiologyMolecular Biology
2001English

Angiotensin II Type-1 Receptor Antagonist as Well as Angiotensin Converying Enzyme Inhibitor Attenuates the Development of Heart Failure in Aortocaval Fistula Rats.

Japanese Circulation Journal
1995English

Angiotensin II Upregulates Acyl-CoA:Cholesterol Acyltransferase-1 via the Angiotensin II Type 1 Receptor in Human Monocyte-Macrophages

Hypertension Research
Internal MedicineCardiovascular MedicinePhysiologyCardiology
2008English

Long-Term Consequences of Fetal Angiotensin II Receptor Antagonist Exposure

Case Reports in Pediatrics
2018English

Angiotensin Receptor Blocker Protection Against Podocyte-Induced Sclerosis Is Podocyte Angiotensin II Type 1 Receptor-Independent

Hypertension
Internal Medicine
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy